Tri Locum Partners LP

Tri Locum Partners LP is a private investment firm based in New York, specializing in healthcare investments across multiple sectors. The firm manages approximately $753 million in assets and offers discretionary investment management to qualified clients through private investment vehicles. Their portfolio includes both public and private opportunities in the healthcare sector, focusing on biotechnology, pharmaceuticals, medical devices, and healthcare services.

The firm's investment strategy employs a market-neutral long/short equity approach, blending deep fundamental, science-based research with proprietary portfolio construction and risk management techniques. This strategy aims to generate superior idiosyncratic returns with high concentration and minimized exposure to macroeconomic and market risks, targeting consistent risk-adjusted performance across all market cycles.

As of June 30, 2025, Tri Locum Partners LP held 23 equity positions with a total market value of $330 million. Their top holdings included Alnylam Pharmaceuticals Inc., Verona Pharma PLC, and Ascendis Pharma A/S. The firm has demonstrated a commitment to the healthcare sector through its investments and strategic approach, positioning itself as a significant player in healthcare-focused private investment.